Canada markets close in 5 hours 26 minutes

Appili Therapeutics Inc. (APLIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02140.0000 (0.00%)
As of 11:50AM EDT. Market open.
Full screen
Loading interactive chart...
  • GlobeNewswire

    Researchers Publish Manuscript on the Prevention and Emergency Response to Tularemia Outbreaks

    A review of Russian and English literature suggests that Appili’s biodefense program ATI-1701 may have a role in preventing tularemia in UkraineHALIFAX, Nova Scotia, March 12, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense products, today announced a publication in the journal Frontiers in Bacteriology on the prevention of tularemia. Appili’s D

  • GlobeNewswire

    Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2024

    FDA approved LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL Additional USAFA funding commitment from the U.S. Air Force Academy, intended to advance the ATI-1701 program toward an IND submission to the FDA Engaging regulatory authorities to align on ATI-1801 development plans HALIFAX, Nova Scotia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious

  • Business Wire

    Appili Therapeutics Announces Issuance of Patent for ATI-1701 Biodefense Vaccine Candidate to Protect Against Tularemia and Provides Update on Bridge Loan

    HALIFAX, Nova Scotia, December 15, 2023--Appili Therapeutics Inc. (TSX:APLI; OTCQB: APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that the United States Patent and Trademark Office ("USPTO") has published patent claims for ATI-1701 under the U.S. Application No. 16/982,322 filed on September 18, 2020 and titled "A Method for Lyophilizing Live Vaccine Strains of Francisella Tularensis". The paten